| |
| |
|
| Insider
Information: |
Browne L Daniel |
| Relationship: |
CEO and President, Dir... |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
152,193 |
|
|
Indirect Shares
|
409 |
|
|
| Direct
Value |
$517,456 |
|
|
|
Indirect Value
|
$1,391 |
|
|
| Total
Shares |
152,602 |
|
|
| Total
Value |
$518,847 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
CEO and President, Dir... |
2019-06-28 |
152,193 |
2019-06-28 |
409 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2019-06-28 |
4 |
A |
$11.02 |
$11,025 |
D/D |
1,000 |
152,193 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2019-03-18 |
4 |
AS |
$15.51 |
$180,068 |
D/D |
(11,613) |
151,193 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2019-03-15 |
4 |
D |
$15.45 |
$94,817 |
D/D |
(6,137) |
162,806 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2019-02-19 |
4 |
AS |
$17.68 |
$96,285 |
D/D |
(5,446) |
168,943 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2019-02-15 |
4 |
D |
$17.69 |
$55,794 |
D/D |
(3,154) |
174,389 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
177,543 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-06-29 |
4 |
A |
$23.33 |
$15,586 |
D/D |
668 |
142,543 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-03-16 |
4 |
AS |
$31.43 |
$171,348 |
D/D |
(5,452) |
141,875 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-03-16 |
4 |
OE |
$2.55 |
$51,000 |
D/D |
20,000 |
147,327 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-03-15 |
4 |
D |
$31.65 |
$91,184 |
D/D |
(2,881) |
127,327 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-03-15 |
4 |
AS |
$32.80 |
$32,800 |
D/D |
(1,000) |
130,208 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-03-07 |
4 |
AS |
$31.43 |
$857,505 |
D/D |
(27,283) |
131,208 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-02-15 |
4 |
D |
$31.75 |
$97,600 |
D/D |
(3,074) |
158,491 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,250 |
161,565 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-12-29 |
4 |
A |
$22.99 |
$2,920 |
D/D |
127 |
133,315 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-11-22 |
4 |
AS |
$24.94 |
$189,570 |
D/D |
(7,600) |
133,188 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-10-18 |
4 |
AS |
$26.16 |
$200,405 |
D/D |
(7,662) |
140,788 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-09-20 |
4 |
AS |
$23.58 |
$179,185 |
D/D |
(7,600) |
148,450 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-08-23 |
4 |
AS |
$22.76 |
$519,031 |
D/D |
(22,800) |
156,050 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-08-23 |
4 |
OE |
$2.55 |
$844 |
D/D |
331 |
178,850 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-06-30 |
4 |
A |
$18.32 |
$18,318 |
D/D |
1,000 |
178,519 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-06-12 |
4 |
OE |
$2.55 |
$21,165 |
D/D |
8,300 |
177,519 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-05-30 |
4 |
OE |
$2.55 |
$12,750 |
D/D |
5,000 |
169,219 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-05-24 |
4 |
AS |
$20.35 |
$401,091 |
D/D |
(19,713) |
164,219 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CEO and President |
• • – |
2017-05-22 |
4 |
AS |
$20.20 |
$248,159 |
D/D |
(12,287) |
183,932 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
